N/A N=52 Randomized Quadruple-blind Supportive Care

Interscalene Brachial Plexus Block Combined With Suprascapular Nerve Block

Rotator Cuff Injury

Bottom Line

View on ClinicalTrials.gov: NCT02424630 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2020

Primary outcome: Primary: Visual Analog Scale (VAS) Pain Score — 2.0; 2.6; 1.7; 2.6 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Ultrasound-guided ISB (Device); Arthroscopy-guided SSNB (Device); Placebo (Drug); Ropivacaine (Drug)
Age: Adult, Older Adult · 20+ yrs
Sex: All
Sponsor: Chuncheon Sacred Heart Hospital
Primary completion: Jul 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Visual Analog Scale (VAS) Pain Score	2.0; 2.6; 1.7; 2.6; 1.6; 4.0	—
SECONDARY Patient Satisfaction (SAT) Score	7.9; 7.2; 7.8; 7.3; 7.8; 6.0	—

Summary

The investigators compared the results of sono-guided interscalene brachial plexus block (ISB) combined with arthroscopy-guided suprascapular nerve block (SSNB) with those of ISB alone within the first 48 h after arthroscopic rotator cuff repair.

Eligibility Criteria

Inclusion Criteria

definite rotator cuff tear on preoperative MRI, which needed repair;
acceptance of arthroscopic surgery including rotator cuff repair;
> 20 years old; and
acceptance of routine regional blocks and patient-controlled analgesia.

Exclusion Criteria

did not want arthroscopic rotator cuff repair;
stopped PCA before 48 h postoperatively due to side effects;
history of shoulder operation or fracture;
concomitant neurological disorder around the shoulder;
conversion to open surgery from the arthroscopy; and
contraindication to the routine regional blocks in this study

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02424630). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.